Supplementary Figure 3 from SOCS3 Transactivation by PPARγ Prevents IL-17–Driven Cancer Growth Article Swipe
Hélène Berger
,
Frédérique Végran
,
Madijd Chikh
,
Federica Gilardi
,
Sylvain Ladoire
,
Hélène Bugaut
,
Grégoire Mignot
,
Fanny Chalmin
,
Mélanie Bruchard
,
Valentin Dérangère
,
Angélique Chevriaux
,
Cédric Rébé
,
Bernhard Ryffel
,
Caroline Pot
,
Aziz Hichami
,
Béatrice Desvergne
,
François Ghiringhelli
,
Lionel Apétoh
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/0008-5472.22394483.v1
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/0008-5472.22394483.v1
PDF file - 50K, In vivo DHA treatment fails to prevent mammary cancer cell growth in vivo in absence of T cells.
Related Topics
Concepts
Transactivation
SOCS3
Cancer research
Internal medicine
Oncology
Cancer
Biology
Medicine
Genetics
Gene
Gene expression
Suppressor
Metadata
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.1158/0008-5472.22394483.v1
- https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_3_from_SOCS3_Transactivation_by_PPAR_Prevents_IL-17_Driven_Cancer_Growth/22394483/1/files/39840095.pdf
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4361894815
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4361894815Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/0008-5472.22394483.v1Digital Object Identifier
- Title
-
Supplementary Figure 3 from SOCS3 Transactivation by PPARγ Prevents IL-17–Driven Cancer GrowthWork title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-03-30Full publication date if available
- Authors
-
Hélène Berger, Frédérique Végran, Madijd Chikh, Federica Gilardi, Sylvain Ladoire, Hélène Bugaut, Grégoire Mignot, Fanny Chalmin, Mélanie Bruchard, Valentin Dérangère, Angélique Chevriaux, Cédric Rébé, Bernhard Ryffel, Caroline Pot, Aziz Hichami, Béatrice Desvergne, François Ghiringhelli, Lionel ApétohList of authors in order
- Landing page
-
https://doi.org/10.1158/0008-5472.22394483.v1Publisher landing page
- PDF URL
-
https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_3_from_SOCS3_Transactivation_by_PPAR_Prevents_IL-17_Driven_Cancer_Growth/22394483/1/files/39840095.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_3_from_SOCS3_Transactivation_by_PPAR_Prevents_IL-17_Driven_Cancer_Growth/22394483/1/files/39840095.pdfDirect OA link when available
- Concepts
-
Transactivation, SOCS3, Cancer research, Internal medicine, Oncology, Cancer, Biology, Medicine, Genetics, Gene, Gene expression, SuppressorTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4361894815 |
|---|---|
| doi | https://doi.org/10.1158/0008-5472.22394483.v1 |
| ids.doi | https://doi.org/10.1158/0008-5472.22394483.v1 |
| ids.openalex | https://openalex.org/W4361894815 |
| fwci | |
| type | preprint |
| title | Supplementary Figure 3 from SOCS3 Transactivation by PPARγ Prevents IL-17–Driven Cancer Growth |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T12996 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 0.9864000082015991 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1305 |
| topics[0].subfield.display_name | Biotechnology |
| topics[0].display_name | Cancer Research and Treatments |
| topics[1].id | https://openalex.org/T10613 |
| topics[1].field.id | https://openalex.org/fields/13 |
| topics[1].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[1].score | 0.9843000173568726 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1311 |
| topics[1].subfield.display_name | Genetics |
| topics[1].display_name | Virus-based gene therapy research |
| topics[2].id | https://openalex.org/T11072 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.9789000153541565 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1312 |
| topics[2].subfield.display_name | Molecular Biology |
| topics[2].display_name | Peroxisome Proliferator-Activated Receptors |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C1292079 |
| concepts[0].level | 4 |
| concepts[0].score | 0.8573178052902222 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q3817769 |
| concepts[0].display_name | Transactivation |
| concepts[1].id | https://openalex.org/C126042315 |
| concepts[1].level | 4 |
| concepts[1].score | 0.5231940746307373 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q18033763 |
| concepts[1].display_name | SOCS3 |
| concepts[2].id | https://openalex.org/C502942594 |
| concepts[2].level | 1 |
| concepts[2].score | 0.5001742839813232 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[2].display_name | Cancer research |
| concepts[3].id | https://openalex.org/C126322002 |
| concepts[3].level | 1 |
| concepts[3].score | 0.3772863447666168 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[3].display_name | Internal medicine |
| concepts[4].id | https://openalex.org/C143998085 |
| concepts[4].level | 1 |
| concepts[4].score | 0.37035080790519714 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[4].display_name | Oncology |
| concepts[5].id | https://openalex.org/C121608353 |
| concepts[5].level | 2 |
| concepts[5].score | 0.3697587847709656 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[5].display_name | Cancer |
| concepts[6].id | https://openalex.org/C86803240 |
| concepts[6].level | 0 |
| concepts[6].score | 0.32993143796920776 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[6].display_name | Biology |
| concepts[7].id | https://openalex.org/C71924100 |
| concepts[7].level | 0 |
| concepts[7].score | 0.29915398359298706 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[7].display_name | Medicine |
| concepts[8].id | https://openalex.org/C54355233 |
| concepts[8].level | 1 |
| concepts[8].score | 0.15637192130088806 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[8].display_name | Genetics |
| concepts[9].id | https://openalex.org/C104317684 |
| concepts[9].level | 2 |
| concepts[9].score | 0.13684386014938354 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q7187 |
| concepts[9].display_name | Gene |
| concepts[10].id | https://openalex.org/C150194340 |
| concepts[10].level | 3 |
| concepts[10].score | 0.0713089108467102 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q26972 |
| concepts[10].display_name | Gene expression |
| concepts[11].id | https://openalex.org/C179185449 |
| concepts[11].level | 3 |
| concepts[11].score | 0.0 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q219699 |
| concepts[11].display_name | Suppressor |
| keywords[0].id | https://openalex.org/keywords/transactivation |
| keywords[0].score | 0.8573178052902222 |
| keywords[0].display_name | Transactivation |
| keywords[1].id | https://openalex.org/keywords/socs3 |
| keywords[1].score | 0.5231940746307373 |
| keywords[1].display_name | SOCS3 |
| keywords[2].id | https://openalex.org/keywords/cancer-research |
| keywords[2].score | 0.5001742839813232 |
| keywords[2].display_name | Cancer research |
| keywords[3].id | https://openalex.org/keywords/internal-medicine |
| keywords[3].score | 0.3772863447666168 |
| keywords[3].display_name | Internal medicine |
| keywords[4].id | https://openalex.org/keywords/oncology |
| keywords[4].score | 0.37035080790519714 |
| keywords[4].display_name | Oncology |
| keywords[5].id | https://openalex.org/keywords/cancer |
| keywords[5].score | 0.3697587847709656 |
| keywords[5].display_name | Cancer |
| keywords[6].id | https://openalex.org/keywords/biology |
| keywords[6].score | 0.32993143796920776 |
| keywords[6].display_name | Biology |
| keywords[7].id | https://openalex.org/keywords/medicine |
| keywords[7].score | 0.29915398359298706 |
| keywords[7].display_name | Medicine |
| keywords[8].id | https://openalex.org/keywords/genetics |
| keywords[8].score | 0.15637192130088806 |
| keywords[8].display_name | Genetics |
| keywords[9].id | https://openalex.org/keywords/gene |
| keywords[9].score | 0.13684386014938354 |
| keywords[9].display_name | Gene |
| keywords[10].id | https://openalex.org/keywords/gene-expression |
| keywords[10].score | 0.0713089108467102 |
| keywords[10].display_name | Gene expression |
| language | en |
| locations[0].id | doi:10.1158/0008-5472.22394483.v1 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_3_from_SOCS3_Transactivation_by_PPAR_Prevents_IL-17_Driven_Cancer_Growth/22394483/1/files/39840095.pdf |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/0008-5472.22394483.v1 |
| locations[1].id | pmh:oai:figshare.com:article/22394483 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S4306400572 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | OPAL (Open@LaTrobe) (La Trobe University) |
| locations[1].source.host_organization | https://openalex.org/I196829312 |
| locations[1].source.host_organization_name | La Trobe University |
| locations[1].source.host_organization_lineage | https://openalex.org/I196829312 |
| locations[1].license | cc-by |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Text |
| locations[1].license_id | https://openalex.org/licenses/cc-by |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | |
| locations[1].landing_page_url | https://figshare.com/articles/journal_contribution/Supplementary_Figure_3_from_SOCS3_Transactivation_by_PPAR_Prevents_IL-17_Driven_Cancer_Growth/22394483 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5112323316 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Hélène Berger |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Hélène Berger |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5046253661 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-4377-1441 |
| authorships[1].author.display_name | Frédérique Végran |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Frédérique Végran |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5059035547 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Madijd Chikh |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Madijd Chikh |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5061488776 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-5421-2779 |
| authorships[3].author.display_name | Federica Gilardi |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Federica Gilardi |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5059810021 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-0331-9194 |
| authorships[4].author.display_name | Sylvain Ladoire |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Sylvain Ladoire |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5015875830 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-5138-4951 |
| authorships[5].author.display_name | Hélène Bugaut |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Hélène Bugaut |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5062163456 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-0682-0152 |
| authorships[6].author.display_name | Grégoire Mignot |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Grégoire Mignot |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5070704309 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-0855-9453 |
| authorships[7].author.display_name | Fanny Chalmin |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Fanny Chalmin |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5090525121 |
| authorships[8].author.orcid | https://orcid.org/0000-0003-0004-2887 |
| authorships[8].author.display_name | Mélanie Bruchard |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Mélanie Bruchard |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5073674085 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-6311-5628 |
| authorships[9].author.display_name | Valentin Dérangère |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Valentin Derangère |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5055217099 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | Angélique Chevriaux |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Angélique Chevriaux |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5035290049 |
| authorships[11].author.orcid | https://orcid.org/0000-0001-8831-145X |
| authorships[11].author.display_name | Cédric Rébé |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Cédric Rébé |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | https://openalex.org/A5024307673 |
| authorships[12].author.orcid | https://orcid.org/0000-0003-2897-8230 |
| authorships[12].author.display_name | Bernhard Ryffel |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Bernhard Ryffel |
| authorships[12].is_corresponding | False |
| authorships[13].author.id | https://openalex.org/A5080968940 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-1146-3129 |
| authorships[13].author.display_name | Caroline Pot |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Caroline Pot |
| authorships[13].is_corresponding | False |
| authorships[14].author.id | https://openalex.org/A5089518272 |
| authorships[14].author.orcid | https://orcid.org/0000-0003-4331-5152 |
| authorships[14].author.display_name | Aziz Hichami |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Aziz Hichami |
| authorships[14].is_corresponding | False |
| authorships[15].author.id | https://openalex.org/A5067434963 |
| authorships[15].author.orcid | https://orcid.org/0000-0001-5483-288X |
| authorships[15].author.display_name | Béatrice Desvergne |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Béatrice Desvergne |
| authorships[15].is_corresponding | False |
| authorships[16].author.id | https://openalex.org/A5043463827 |
| authorships[16].author.orcid | https://orcid.org/0000-0002-5465-8305 |
| authorships[16].author.display_name | François Ghiringhelli |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | François Ghiringhelli |
| authorships[16].is_corresponding | False |
| authorships[17].author.id | https://openalex.org/A5088229816 |
| authorships[17].author.orcid | https://orcid.org/0000-0002-2774-438X |
| authorships[17].author.display_name | Lionel Apétoh |
| authorships[17].author_position | last |
| authorships[17].raw_author_name | Lionel Apetoh |
| authorships[17].is_corresponding | False |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_3_from_SOCS3_Transactivation_by_PPAR_Prevents_IL-17_Driven_Cancer_Growth/22394483/1/files/39840095.pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Supplementary Figure 3 from SOCS3 Transactivation by PPARγ Prevents IL-17–Driven Cancer Growth |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T12996 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 0.9864000082015991 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1305 |
| primary_topic.subfield.display_name | Biotechnology |
| primary_topic.display_name | Cancer Research and Treatments |
| related_works | https://openalex.org/W2748808514, https://openalex.org/W2347629752, https://openalex.org/W4285386899, https://openalex.org/W2073080535, https://openalex.org/W2042229191, https://openalex.org/W1973008001, https://openalex.org/W2130076355, https://openalex.org/W2033825599, https://openalex.org/W2115669156, https://openalex.org/W2801645180 |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1158/0008-5472.22394483.v1 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_3_from_SOCS3_Transactivation_by_PPAR_Prevents_IL-17_Driven_Cancer_Growth/22394483/1/files/39840095.pdf |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/0008-5472.22394483.v1 |
| primary_location.id | doi:10.1158/0008-5472.22394483.v1 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_3_from_SOCS3_Transactivation_by_PPAR_Prevents_IL-17_Driven_Cancer_Growth/22394483/1/files/39840095.pdf |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/0008-5472.22394483.v1 |
| publication_date | 2023-03-30 |
| publication_year | 2023 |
| referenced_works_count | 0 |
| abstract_inverted_index.- | 2 |
| abstract_inverted_index.T | 20 |
| abstract_inverted_index.In | 4 |
| abstract_inverted_index.in | 15, 17 |
| abstract_inverted_index.of | 19 |
| abstract_inverted_index.to | 9 |
| abstract_inverted_index.DHA | 6 |
| abstract_inverted_index.50K, | 3 |
| abstract_inverted_index.cell | 13 |
| abstract_inverted_index.file | 1 |
| abstract_inverted_index.vivo | 5, 16 |
| abstract_inverted_index.fails | 8 |
| abstract_inverted_index.cancer | 12 |
| abstract_inverted_index.growth | 14 |
| abstract_inverted_index.absence | 18 |
| abstract_inverted_index.mammary | 11 |
| abstract_inverted_index.prevent | 10 |
| abstract_inverted_index.treatment | 7 |
| abstract_inverted_index.<p>PDF | 0 |
| abstract_inverted_index.cells.</p> | 21 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 18 |
| citation_normalized_percentile.value | 0.11630488 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |